The sinoatrial node (SAN) is the primary pacemaker in mammalian hearts and is vital to cardiac function. Genetic mutations in SAN can result in lose-of-function of ion channels, consequently arouse sinus node dysfunction (SND), Brugada syndrome (BrS) and progressive cardiac conduction disease (PCCD). The mechanisms underlying the he pathogenesis for cardiac pacemaker dysfunctions associated with genetic mutations has not been defined. In this project, by using computer modeling, mechanisms by which the HCN4 mutations impair cardiac pacemaking and possible pro-arrhythmic effects of ivabradine were investigated. Action potential (AP) models for rabbit sinoatrial node cells were modified to incorporate experimentally reported If changes induced by HCN4 gene mutations. At both the cellular and intact SAN-atrium tissue level, If reduction due to the HCN4 mutations slowed down pacemaking. At the tissue level, these mutations compromised the AP conduction across the SAN-atrium, leading to a possible sinus arrest or SAN exit block. Moreover, vagal nerve activity could amplify the bradycardiac effects of the HCN4 gene mutations, leading to sinus arrest and SAN exit block that was not observed with the mutations or ACh alone. Similarly, SND associated with SCN5A mutations and acquired cardiac conditions were studied. 1) Mathematical models of rabbit SAN cells and 2D tissue models were modified to investigate SAN function and intracardiac conduction in a murine model of long QT syndrome type 3. A prolonged tail current INa,L was introduced and incorporated with a normal INa,T to test the SAN pacemaker function and AP conduction from the SAN to atrial septum. Simulation results showed that a combined reduction in INa,T and introduction of INa,L achieved alterations in both pacemaking rate and conduction. 2) Mathematical models of mouse SAN cells were modified to investigate the mechanisms underlies the SAN associated with SCN5A deficiency and aging. A coupled SAN-atrium cell model was developed to replicate the experimentally observed slowing of SAN conduction with aging and SCN5A-disruption The modelling studies reconstructed the physiological mechanisms by which both aging and SCN5A-disruption lead to SND, thereby drawing parallels between these and similar conduction changes in the ventricle that occur in the possibly related condition of PCCD. At last, a 2D anatomically based model of the SAN-atrium was constructed. This model successfully reproduced the effects of vagal nerve stimulation and SCN5A-E161K gene mutation on spontaneous activity of the SAN and AP conduction across the SAN-atrium.

L'unité de recherche EA4612 de l'Université Claude Bernard Lyon 1 s'intéresse à la physiopathologie des troubles du rythme cardiaque, en particulier d'origine héréditaire. Nous avons étudié des mutations de gène de canaux ioniques découvertes chez des patients hétérozygotes atteints d'un syndrome du QT long ou de bradycardie sinusale et de fibrillation atriale. La mutation R148W du gène hERG diminue le courant maximal de 29%. Dans un modèle mathématique, ceci allonge la durée du potentiel d'action ventriculaire, ce qui pourrait rendre compte du phénotype QT long des porteurs. La mutation F627L du gène hERG se situe au centre du motif de sélectivité ionique (GFG) de la protéine hERG. Elle cause une perte de la sélectivité ionique du courant, de la propriété d'inactivation et de la sensibilité aux bloqueurs spécifiques. Ainsi, la présence du groupement aromatique de la chaîne latérale semble essentielle au maintien des propriétés du canal. La mutation Q1476R du gène SCN5A provoque un gain de fonction du courant sodique persistant. Dans un modèle de cellule cardiaque ventriculaire humaine, nous montrons une surcharge sodique intracellulaire pouvant protéger de l'allongement de la durée du potentiel d'action ventriculaire. La mutation D600E du gène HCN4 accélère la désactivation, ce qui pourrait causer une bradycardie. Par ailleurs, la mutation abolit la réponse à la suppression de l'adénosine monophosphate cyclique (AMPc) intracellulaire. La mutation V501M du gène HCN4 cause une perte totale de courant à l'état homozygote. A l'état hétérozygote, l'amplitude moyenne du courant est inchangée par rapport au WT. Cependant, un décalage négatif de la courbe d'activation rendrait compte de la bradycardie des patients porteurs / The EA4612 unit of the University Lyon 1 focuses on the pathophysiology of heart rhythm disorders, especially hereditary. We studied ion channel gene mutations discovered in heterozygote patients with long QT syndrome or sinus bradycardia and atrial fibrillation.The R148W mutation of the hERG gene decreases the maximum current by 29%. In a mathematical model, this lengthens the duration of the ventricular action potential, which could account for long QT phenotype of the patients. The F627L mutation of the hERG gene is in the center of the ion selectivity filter (GFG) of the hERG protein. It causes a loss of the ionic selectivity of the current, the inactivating property and sensitivity to specific blockers. Thus, the presence of this aromatic group of the side chain seems to be essential to the maintenance of the channel properties. The mutation Q1476R in the SCN5A gene causes a gain-of-function of the persistent sodium current. In a model of human ventricular heart cells, we show an intracellular sodium overload that can protect against the lengthening of the duration of the ventricular action potential. The D600E mutation of the HCN4 gene accelerates deactivation, which could cause bradycardia. Moreover, the mutation abolishes the response to the suppression of intracellular cyclic adenosine monophosphate (cAMP). The V501M mutation of the HCN4 gene causes a total loss of current in the homozygous state. In the heterozygous state, the average amplitude of the current is unchanged from the WT. However, a negative shift of the activation curve would account for bradycardia in patients

acase@tulane.edu

The sinus node (SN) is the natural pacemaker of the heart. In the human, the SN is surrounded by the paranodal area (PNA), the function of which is currently unknown. The PNA may act as subsidiary atrial pacemakers (SAP) and become the dominant pacemaker during sinus node dysfunction (SND). Creation of an animal model of SND allows characterisation of SAP, which can be a target for novel treatment strategies other than the currently available electronic pacemakers. I developed a large animal model of SND by ablating the SN in the goat and validated it by mapping the location of the newly emergent SAP. Functional characterisation of the SAP revealed reduced atrioventricular (AV) conduction time consistent with a location of the SAP close to the AV junction. SAP recovery time showed an initially significant prolongation compared to the SN recovery time, followed by a gradual decrease over 4 weeks. SAP pauses, and temporary reliance on electronic pacemaker activity have also been demonstrated then disappeared over time, suggesting possible modulation, maturation of the SAP. Structural characterisation of the SN revealed an extensive pacemaking complex within the right atrium (RA); the SN was surrounded by the PNA, extending down to the inferior vena cava (IVC) and into the interatrial groove. The PNA had a histological appearance that is intermediate to the SN and the RA. 3D reconstruction demonstrated, for the first time in a large animal model, an extensive and almost complete circle of pacemaking tissue at the junction of the embryologically different sinus venosus and the muscular right atrium. The SAP emerged in a location close to the IVC along the crista terminalis. Expression of key ion channel proteins in the SAP showed abundance of the pacemaker channel (HCN4) and the sodium/calcium exchanger (NCX1) compared to RA, similar to the expression pattern of the SN. The expression of the main high conductance connexin (Cx43) was not significantly different between SAP and RA, and both expressed Cx43 more abundantly than the SN.Conclusion: Destruction of the sinus node in this experimental model resulted in the generation of chronic SAP activity in the majority of the animals. The SAP displayed maturation over time and located in the inferior part of the RA, in the same area where the PNA was found in controls, suggesting the role of PNA as the dominant pacemaker in sinus node dysfunction. The SAP in the goat constitutes a promising stable target for electrophysiological modification to construct a fully functioning biological pacemaker.